Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014.
Lysosomal Storage Disease Clinical Care Network, Pittsburgh, PA.
John A
JA
Barranger
Roscoe O
RO
Brady
Gregory A
GA
Grabowski
Henry
H
Mankin
Pramod K
PK
Mistry
Neal J
NJ
Weinreb
D056947:Enzyme Replacement Therapy / Q000379:methods*; D005776:Gaucher Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology; D005962:Glucosylceramidase / Q000627:therapeutic use; D006801:Humans; D007348:Insurance, Health; D014481:United States
D005962:Glucosylceramidase; C550184:Velaglucerase alfa, human; C582473:taliglucerase alfa; C090568:imiglucerase